U.S. Markets open in 5 hrs, 20 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,318.16 | -14.28 | -0.14% |
| NASDAQ | 2,146.04 | -10.78 | -0.50% |
| S&P 500 | 1,091.38 | -3.52 | -0.32% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 3.93 12:47 PM EST | |
|---|---|---|
| Day High | 4.09 09:30 AM EST |
|
| Range | 0.16 |
| Volume | 307,663 | |
|---|---|---|
| 30-Day Avg Vol | 186,000 |
|
| Difference | 65.41% |
| Market Cap | 128.87 M | |
|---|---|---|
| Mkt Cap Chg | 2.53 M |
| Shares Out | 31.66 M | |
|---|---|---|
| % Shrs Traded | 0.97% | |
| 1yr EPS Est | -1.425 |
| 52-Wk Low | 3.53 | |
|---|---|---|
| 52-Wk High | 10.81 |
|
| Range | 7.28 |
| Prev Close | 3.99 11/19/09 | |
|---|---|---|
| Today's Open | 3.99 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.53 M |
| Revenue (LFY) | 67.67 M | |
|---|---|---|
| Earnings (LFY) | -44.67 M | |
| Earnings (MRQ) | -13.01 M | |
| Next Earn Est | -0.15 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -1.46 | |
| 1yr EPS Growth | 1.72% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -32.79 | |
| Beta | 1.45 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Progenics Pharmaceuticals is taking a proactive approach to fighting serious diseases such as HIV and cancer. The biotech company won its first FDA approval in 2008 with Relistor (methylnatrexone), which ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.15 3/8/10 | — — |
—
—
|
| Last Quarter | -0.436 9/30/09 | -0.41 9/30/09 |
0.026
Beat
|
| 2 Quarters Ago | -0.512 6/30/09 | -0.49 6/30/09 |
0.022
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 5.42 M | 67.67 M |
| Gross Profit | -6.38 M | 63.06 M |
| Operating Income | -13.16 M | -50.91 M |
| Net Income | -13.01 M | -44.67 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts